NetworkNewsBreaks

FridayApr 17, 2020 1:19 pm

NetworkNewsBreaks – Xeris Pharmaceuticals Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report

Xeris Pharmaceuticals Inc. (NASDAQ: XERS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We applied a weighted average valuation methodology (DCF+EV/Sales) to derive our $18PT. Our assumptions include: Launch of the glucagon rescue pen in the U.S. market in 4Q19, with peak-sales of $399 mil in 2029. DCF Assumptions: Terminal value of 4.0x 2029 FCF and 13% discount rate to derive a $20 PT. EV/Sales Assumptions: 4.0x multiple of 2025 sales, discounted at 13% to derive a $16 PT. Additional pipeline indications represent upside to our current price target.” To request…

Continue Reading

FridayApr 17, 2020 12:15 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters Securities Purchase Agreement to Raise $3.5 Million

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently entered into a securities purchase agreement with certain accredited investors to purchase shares of common stock (http://nnw.fm/r6SCU). An article discussing the company reads, “The company explained that it has entered into a securities purchase agreement with certain accredited investors to raise $3.5 million through the issuance of up to 1,650,165 shares of common stock (or common stock equivalents) and accompanying warrants to purchase an aggregate of up to 3,300,330 shares of common stock at $2.121 per share of common stock and…

Continue Reading

FridayApr 17, 2020 12:09 pm

NetworkNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Poised to Profit as Vacation-Rental Industry Forecasted to Skyrocket Over Coming Years

Travel-accommodations insurance provider InsuraGuest Technologies (TSX.V: ISGI) is positioned to benefit from the major growth trajectory in the vacation-rental space after the anticipated recovery of the hospitality sector. A recent article discussing the company reads, “In 2019, the vacation rental industry generated revenues of $57.7 billion (http://nnw.fm/4hrfF), with sales expected to rise to $97.01 billion by 2023 (http://nnw.fm/31oWe). Increasingly, travelers are opting for vacation rentals rather than hotels during their trips, with 71% of travelers with children saying that the ability to cook their own meals was a major draw. However, despite the rising penetration rate of vacation rentals, growth…

Continue Reading

FridayApr 17, 2020 12:04 pm

NetworkNewsBreaks – Aerie Pharmaceuticals Inc. (NASDAQ: AERI) Featured in Mizuho Securities Research Report

Aerie Pharmaceuticals Inc. (NASDAQ: AERI) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We applied a weighted average valuation (DCF and EV/Sales) to derive our $34 PT. Our assumptions include: Rhopressa: U.S. peak-sales of $162 mil in 2025. Rocklatan: U.S. peak-sales of $331 mil in 2025. DCF Assumptions: Terminal value of 5x 2028 FCF and a 13% discount rate to derive a $40 PT. EV/Sales Assumptions: 3.8x multiple of 2028 sales, discounted at 13% to derive a $27 PT. In our bull case scenario, we assume greater than anticipated market share…

Continue Reading

FridayApr 17, 2020 10:37 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Interview to Air on The RedChip Money Report

SinglePoint (OTCQB: SING) today announced that an interview with its President Wil Ralston will air on The RedChip Money Report television program. Per the update, the interview is scheduled to air on Sunday, April 19, at 3 PM local time on Bloomberg International, available in 100+ million homes across Europe. Ralston provides insight into the company's rapidly growing solar business in the exclusive interview, which will also air in the U.S. on the Family Channel at 6 PM on April 22, the Action Channel at 11 AM on Sunday, April 19, and is available via live stream on American Business…

Continue Reading

FridayApr 17, 2020 10:25 am

NetworkNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) President and CFO to Host Briskie Business on ENTV USA

Youngevity International (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, commercial hemp enterprise and multi-channel lifestyle company, today announced that its President and CFO Dave Briskie will premier an hour long show titled Briskie Business on Wednesday, April 22, on the ENTV Digital Platform. According to the update, ENTV USA selected Briskie to host the show based on his unique combination of experience in marketing and finance in global markets along with his focus on social responsibility at every level of the organizations that he has helped build. “The arrangement with…

Continue Reading

FridayApr 17, 2020 10:03 am

NetworkNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Discusses New Revenue Streams on MoneyTV with Donald Baillargeon

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives that offer insights into various companies and their operations and future outlooks. Among other highlights, this week’s episode featured CIIX CEO Warren Wang as he discussed the company generating new streams of revenue via its new YouTube program. To view the full press release, visit http://nnw.fm/ALe54 About ChineseInvestors.com Inc. Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by…

Continue Reading

FridayApr 17, 2020 9:26 am

NetworkNewsBreaks – National Storm Recovery Inc. (NSRI) Posts Corporate Update Regarding COVID-19

National Storm Recovery (OTC: NSRI) a provider of tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products, on Thursday issued a corporate update on first-quarter sales and company management’s strategies to support employees and shareholders amid the coronavirus pandemic. As a result of the company’s long-standing, strong relationships with its customers, including big box retailers that are considered essential businesses, revenues from its recently acquired Mulch Manufacturing subsidiary were $7.3 million for the first quarter of 2020. Though cash flow remains strong, its Mulch Manufacturing subsidiary has been approved to receive $1,458,200 in…

Continue Reading

ThursdayApr 16, 2020 3:30 pm

NetworkNewsBreaks – Arcus Biosciences Inc. (NYSE: RCUS) Featured in Mizuho Securities Research Report

Arcus Biosciences Inc. (NYSE: RCUS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Shares of RCUS are trading up ~50% after hours which we believe to be associated with a Bloomberg article indicating that GILD (Buy, $81 PT, covered by Mizuho analyst Salim Syed) is considering acquiring a stake in the company. RCUS has a number of I/O clinical assets, with AB154 (anti-TIGIT) receiving considerable attention following the advancement of a competitor candidate (Roche's tiragolumab) into Phase III studies earlier this year. Bottom line for us that is that partner activity…

Continue Reading

ThursdayApr 16, 2020 2:39 pm

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) and RedShiftBio Combine Proprietary Technology to Create Powerful Biotherapeutic Drug Development Platform

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, today announced that the combination of PBIO's patented Pressure Cycling Technology ("PCT") with RedShiftBio's proprietary Microfluidic Modulation Spectroscopy ("MMS") has resulted in a powerful new platform for biotherapeutic drug development ("PCT-enhanced MMS"). PBIO believes combining both platforms enables for the rigorous investigation of protein structure and stability in a highly efficient workflow that can be crucial in drug development. Per the release, the collaboration should result in faster development of new drugs…

Continue Reading